Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 1,300 shares at $25.24 ($33K) on 2021-04-30, disclosed to the SEC on 2021-04-30.
Scheduled sale ($33k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.06 | 700 | $18K | 53.7% |
| 2 | $25.24 | 600 | $15K | 46.3% |
| Total | $25.14 avg | 1,300 | $33K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |